TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›WEX
WEX logo

WEX

WEX Inc.

Next earnings Jul 21, 2026 (before open) · consensus $5.10 EPS, $746M rev

Last earnings +4.2% on 2026-04-22

Buy
$146.48
▲ +7.13%
$146.48▼ -0.27%
over 1Y
L $126.86H $184.93
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+7.1%
1W+10.1%
1M-1.3%
3M-5.3%
YTD-1.3%
1Y-0.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
C+
Valuation
Overvalued
Filings
Clean
Buy
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 18 analysts
Buy

Cheap cash-gusher buying back ~16% of float a year at 15.9x earnings — the leverage optics overstate the real risk.

P/E (trailing) 15.9 · FY2025

The read

The fundamentals carry the rating, but the price is rich (~51% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.

WEX is a high-margin, cash-generative payments-and-benefits franchise trading at just 15.9x trailing diluted EPS and 2.5x sales, despite a 36.0% operating margin, 16.5% net margin and a 24.6% ROE. FY2025 revenue slipped 1.2% to $1.85B and net income eased 1.8% to $304M, but diluted EPS still grew 12.9% to $8.47 because the company hammered share count down 11.6% via $750M of buybacks (up 15.0% YoY). That is the entire setup: a slow-growth, durably profitable business returning enormous amounts of capital, with the per-share line meaningfully outrunning the absolute P&L.

The scary-looking 10.66x liabilities/equity ratio is mostly a feature of WEX Bank's industrial-bank balance sheet, not corporate leverage. The MD&A confirms the credit-agreement covenant tests a 'consolidated leverage ratio of less than 3.50:1.00' that explicitly excludes up to $400M of permitted securitizations, the non-recourse portion of factoring, and up to $500M of unrestricted cash — i.e. the headline liabilities figure is not what the lenders price. Long-term debt of $3.53B against $664M operating income and $906M cash (up 52% YoY) is workable, and $454M of operating cash flow comfortably covers $141M of capex. Retained earnings rose 14.7% to $2.37B even after the buyback — equity only shrank because management is aggressively retiring stock, which is the right move at this multiple.

Is WEX a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread (wide)~60d expiry
  • Long call 146 @ ~10.73 est
  • Short call 168 @ ~3.46 est
debit $727max +$1,473max −$727BE 153.27

High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.35B$1.69B$1.84B$1.87B$1.85B
Gross profit—————
Operating income$342M$470M$647M$686M$664M
Net income$135M$167M$267M$310M$304M
Diluted EPS$0.00$4.50$6.16$7.50$8.47
Net margin10.1%9.9%14.5%16.6%16.5%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$7.76B
EV / EBITDA7.8
EV / Sales4.2
EV / FCF24.7
P / FCF16.2
PEG (trailing)—
Earnings yield6.0%
FCF yield6.2%

Quality & risk

ROIC (est.)10.9%
Free cash flow$314M
Total debt$3.59B
Net cash-$2.68B
Altman Z-Score0.78 distress
Piotroski F-Score5/8

Capital returns

Buyback yield14.8%
Dividend yield (est.)—
Shareholder yield14.8%
Shares Δ YoY-11.6%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Shareholder vote2026-05-14

    Annual meeting vote results disclosed; routine governance update for shareholders.

  2. 8-K Material agreement2026-05-04

    Entered material agreement (Item 1.01) with Reg FD disclosure; terms shape capital structure.

  3. 10-Q Quarterly report2026-04-23

    Q1 2026 10-Q filed; quarterly financials and MD&A for the period ended 2026-03-31.

  4. 8-K Earnings results2026-04-22

    Q1 2026 earnings release furnished; results drive +3% move and frame full-year outlook.

  5. 10-K Annual report2026-02-13

    FY25: rev -1.2%, NI -1.8%, but $750M buyback (-11.6% shares) lifted diluted EPS +12.9%.

  6. 8-K Earnings results2026-02-04

    Q4/FY25 earnings: rev -1.2% but diluted EPS +12.9% on $750M buyback shrinking float.

  7. 8-K Officer / director change2026-01-12

    Officer/director change announced (Item 5.02); leadership transition signal for holders.

  8. 10-Q Quarterly report2025-10-30

    Q3 2025 10-Q filed; interim results and risk/MD&A disclosure for the quarter.

  9. 8-K Officer / director change2025-10-29

    Q3 2025 earnings paired with officer change; mixed signal on execution continuity.

Recent filings

all on EDGAR ↗
4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-172026-06-22open ↗4Period ending 2026-06-172026-06-22open ↗4Period ending 2026-05-282026-06-01open ↗144Filing2026-05-28open ↗4Period ending 2026-05-182026-05-20open ↗4Period ending 2026-05-142026-05-18open ↗3Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueB
GrowthF
ProfitabilityA
Financial healthC+
MomentumC-
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✗Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$71.28

Overvalued -51% vs price

cheapfair valueexpensive

Modified Graham: EPS $8.47 × (8.5 + 1.5 × 0.0% growth) × 0.99 quality = 8.4× multiple. An estimate, not a price target.

126.8652-week184.93
Revenue
$1.85B
-1.2% YoY
Net margin
16.5%
ROE
24.6%
P/E
17.3

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.85B-1.2%
Net income$304M-1.8%
Operating income$664M-3.3%
Diluted EPS$8.47+12.9%
Cash & equivalents$906M+52.0%
Total assets$14.4B+8.1%
Total liabilities$13.2B+11.3%
Stockholders' equity$1.23B-17.1%
Op.: 36.0%L/E: 10.66x

Frequently asked

Is WEX Inc. (WEX) a buy?
WEX currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Cheap cash-gusher buying back ~16% of float a year at 15.9x earnings — the leverage optics overstate the real risk.
What is WEX's fair value?
A Modified-Graham model based on WEX's SEC fundamentals estimates a fair value of about $71.28. It is an estimate from reported earnings, not a price target.
Is WEX overvalued or undervalued?
Against a Modified-Graham fair-value estimate, WEX currently appears overvalued relative to its SEC-grounded earnings power.
What is WEX Inc.'s quality score?
WEX scores 63.41724121822976/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001309108, latest 10-Q filed 2026-04-23) · EODHD · Proprietary analysis · as of 6/25/2026, 12:46:52 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 8:46 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 1 sale

2026-06-30
Wolfe Lauren Taylor
Director
Award79.00
2026-06-30
GROCH JAMES R
Director
Award186.00
2026-06-30
Callahan Don
Director
Award186.00
2026-06-30
Adams Kurt Patrick
Director
Award79.00
2026-06-17
Trickett Sara
Chief Legal Officer
Exercise98.00
2026-06-17
Trickett Sara
Chief Legal Officer
Tax29.00 @ $131.27$3.81K
2026-06-17
Trickett Sara
Chief Legal Officer
Exercise75.00
2026-06-17
Trickett Sara
Chief Legal Officer
Tax23.00 @ $131.27$3.02K
2026-06-17
Carriedo Carlos
COO, Amer. Payments & Mobility
Exercise391.00
2026-06-17
Carriedo Carlos
COO, Amer. Payments & Mobility
Tax174.00 @ $131.27$22.8K
2026-05-28
Deshaies Robert Joseph
COO, Benefits
Sell1.20K @ $144.84$174K
2026-05-18
GROCH JAMES R
Director
Buy1.50K @ $142.95$214K

Earnings history

beat/miss · move
2026-04-22Beat +1.0% est▼ -15.82%8-K ↗
2026-02-04Beat +3.8% est▼ -5.77%8-K ↗
2025-10-29Beat +2.5% est▼ -8.76%8-K ↗
2025-07-23Beat +5.9% est▲ +13.38%8-K ↗
2025-04-30—▼ -5.26%8-K ↗
2025-02-05—▼ -18.45%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-06-18Kelly Louise MorrisonSell$1.00K–$15.0KPTR ↗
2018-08-14Alan S. LowenthalSell$1.00K–$15.0KPTR ↗
2018-08-14Alan S. LowenthalSell$589.00+PTR ↗
2018-07-27Alan S. LowenthalSell$1.00K–$15.0KPTR ↗
2018-07-27Alan S. LowenthalSell$589.00+PTR ↗
2018-06-10Alan S. LowenthalSell$1.00K–$15.0KPTR ↗
2018-06-10Alan S. LowenthalSell$554.00+PTR ↗
2017-10-10Alan S. LowenthalBuy$1.00K–$15.0KPTR ↗
2016-10-12K. Michael ConawaySell$1.00K–$15.0KPTR ↗
2016-03-03Thomas MacArthurSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score63 vs 67
Revenue growth-1.2% vs 7.5%
Net margin16.5% vs 10.0%
Return on equity24.6% vs 12.0%
P/E17.3 vs 26.2